<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cueto R</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Natural Science Foundation of China</funding><funding>National Institutes of Health</funding><pagination>70-88</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6006524</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17</volume><pubmed_abstract>Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease (CVD) which has been implicated in matochondrial (Mt) function impairment. In this study, we characterized Hcy metabolism in mouse tissues by using LC-ESI-MS/MS analysis, established tissue expression profiles for 84 nuclear-encoded Mt electron transport chain complex (nMt-ETC-Com) genes in 20 human and 19 mouse tissues by database mining, and modeled the effect of HHcy on Mt-ETC function. Hcy levels were high in mouse kidney/lung/spleen/liver (24-14 nmol/g tissue) but low in brain/heart (~5 nmol/g). S-adenosylhomocysteine (SAH) levels were high in the liver/kidney (59-33 nmol/g), moderate in lung/heart/brain (7-4 nmol/g) and low in spleen (1 nmol/g). S-adenosylmethionine (SAM) was comparable in all tissue</pubmed_abstract><journal>Redox biology</journal><pubmed_title>Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment.</pubmed_title><pmcid>PMC6006524</pmcid><funding_grant_id>R01 HL116917</funding_grant_id><funding_grant_id>HL9445</funding_grant_id><funding_grant_id>R01 DK113775</funding_grant_id><funding_grant_id>DK113775 (HW)</funding_grant_id><funding_grant_id>HL108910</funding_grant_id><funding_grant_id>HL82774</funding_grant_id><funding_grant_id>R01 HL138749</funding_grant_id><funding_grant_id>R01 HL077288</funding_grant_id><funding_grant_id>DK104114</funding_grant_id><funding_grant_id>HL77288</funding_grant_id><funding_grant_id>R01 HL108910</funding_grant_id><funding_grant_id>R01 HL130233</funding_grant_id><funding_grant_id>81330004</funding_grant_id><funding_grant_id>R01 HL132399</funding_grant_id><funding_grant_id>HL116917 (XFY)</funding_grant_id><funding_grant_id>F32 HL009445</funding_grant_id><funding_grant_id>R01 HL131460</funding_grant_id><funding_grant_id>HL67033</funding_grant_id><funding_grant_id>R01 HL110764</funding_grant_id><funding_grant_id>R01 HL117654</funding_grant_id><funding_grant_id>HL131460</funding_grant_id><funding_grant_id>R01 HL082774</funding_grant_id><funding_grant_id>HL130233</funding_grant_id><funding_grant_id>HL-110764</funding_grant_id><funding_grant_id>R01 HL067033</funding_grant_id><funding_grant_id>91639204 (YJ)</funding_grant_id><pubmed_authors>Lavallee M</pubmed_authors><pubmed_authors>Shan HM</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Cueto R</pubmed_authors><pubmed_authors>Li YF</pubmed_authors><pubmed_authors>Yang WY</pubmed_authors><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Lopez J</pubmed_authors><pubmed_authors>Yu C</pubmed_authors><pubmed_authors>Huang X</pubmed_authors><pubmed_authors>Ji Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification of homocysteine-suppressive mitochondrial ETC complex genes and tissue expression profile - Novel hypothesis establishment.</name><description>Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease (CVD) which has been implicated in matochondrial (Mt) function impairment. In this study, we characterized Hcy metabolism in mouse tissues by using LC-ESI-MS/MS analysis, established tissue expression profiles for 84 nuclear-encoded Mt electron transport chain complex (nMt-ETC-Com) genes in 20 human and 19 mouse tissues by database mining, and modeled the effect of HHcy on Mt-ETC function. Hcy levels were high in mouse kidney/lung/spleen/liver (24-14 nmol/g tissue) but low in brain/heart (~5 nmol/g). S-adenosylhomocysteine (SAH) levels were high in the liver/kidney (59-33 nmol/g), moderate in lung/heart/brain (7-4 nmol/g) and low in spleen (1 nmol/g). S-adenosylmethionine (SAM) was comparable in all tissue</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Jul</publication><modification>2026-04-29T05:05:27.642Z</modification><creation>2019-03-26T23:42:32Z</creation></dates><accession>S-EPMC6006524</accession><cross_references><pubmed>29679893</pubmed><doi>10.1016/j.redox.2018.03.015</doi></cross_references></HashMap>